cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Bio Techne Corp
2 own
13 watching
Current Price
$75.45
$-0.47
(-0.62%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
11,467.44M
52-Week High
52-Week High
89.91000
52-Week Low
52-Week Low
51.79000
Average Volume
Average Volume
0.46M
Dividend Yield
Dividend Yield
0.002574
P/E Ratio
P/E Ratio
143.3873
iconMarket Capitalization11,467.44M
icon52-Week High89.91000
icon52-Week Low51.79000
iconAverage Volume0.46M
iconDividend Yield0.002574
iconP/E Ratio143.3873
What does the Bio Techne Corp do?
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide. The company operates through three segments: Biotechnology, Clinical Controls, and Protein Platforms. The Biotechnology segment provides proteins, such as cytokines, growth factors, and enzymes; polyclonal antibodies in goats, sheep, and rabbits, as well as monoclonal antibodies; microtiter-plate based kits, immunoassays based on encoded bead technology and planar spotted surfaces, and microfluidic-based immunoassays to quantify the level of a specific protein in biological fluids; and erythropoietin, transferrin receptor, and Beta2-microglobulin immunoassays for use as in vitro diagnostic devices. This segment also offers fluorochrome labeled antibodies and kits to determine the immuno-phenotypic properties of cells from various tissues; and natural or synthetic chemical compounds for use as agonists, antagonists, and/or inhibitors of various biological functions. The Clinical Controls segment provides hematology controls and calibrators for hematology clinical instruments; clinical controls for blood glucose and blood gas devices, as well as coagulation device control products; and bulk purified proteins, enzymes, disease-state plasmas, infectious disease antigens, and processed serums to the clinical diagnostic industry. The Protein Platforms segment develops, manufactures, and sells tools comprising Simple Western platform, an assay for protein analysis and identification; SimplePlex platform, an assay used in research and clinical diagnostics; and Biologics Instrumentation to interrogate protein purity and identify contaminants during the development and production of biologics. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Read More
How much money does Bio Techne Corp make?
News & Events about Bio Techne Corp.
Ticker Report
1 year ago
Sumitomo Mitsui Trust Holdings Inc. grew its position in Bio-Techne Co. (NASDAQ:TECH Get Rating) by 302.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,014,575 shares of the biotechnology companys stock after purchasing ...
PR Newswire
1 year ago
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS PR Newswire MINNEAPOLIS, April 12, 2023 MINNEAPOLIS, April 12, 2023 /PRNewswire/ --Bio-Techne...
Zolmax
1 year ago
Bio-Techne Co. (NASDAQ:TECH Get Rating) has received an average rating of Moderate Buy from the twelve analysts that are currently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. ...
PR Newswire
1 year ago
BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, March 10, 2023 MINNEAPOLIS, March 10, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive...
PR Newswire
1 year ago
BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE PR Newswire MINNEAPOLIS, Feb. 28, 2023 MINNEAPOLIS, Feb.28, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth...
Frequently Asked Questions
Frequently Asked Questions
What is Bio Techne Corp share price today?
plus_minus_icon
Can Indians buy Bio Techne Corp shares?
plus_minus_icon
How can I buy Bio Techne Corp shares from India?
plus_minus_icon
Can Fractional shares of Bio Techne Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Bio Techne Corp stocks?
plus_minus_icon
What is today’s traded volume of Bio Techne Corp?
plus_minus_icon
What is today’s market capitalisation of Bio Techne Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Bio Techne Corp?
plus_minus_icon
What percentage is Bio Techne Corp down from its 52-Week High?
plus_minus_icon
What percentage is Bio Techne Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$75.45
$-0.47
(-0.62%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00